527 related articles for article (PubMed ID: 27492693)
21. Congenital fibrinogen disorder caused by digenic mutations of the
Wang X; Tang N; Shen N; Lu Y; Li D
Hematology; 2020 Dec; 25(1):145-148. PubMed ID: 32228225
[No Abstract] [Full Text] [Related]
22. Mutational Epidemiology of Congenital Fibrinogen Disorders.
Casini A; Blondon M; Tintillier V; Goodyer M; Sezgin ME; Gunes AM; Hanss M; de Moerloose P; Neerman-Arbez M
Thromb Haemost; 2018 Nov; 118(11):1867-1874. PubMed ID: 30332696
[TBL] [Abstract][Full Text] [Related]
23. Congenital dysfibrinogenemia in major surgery: A description of four cases and review of the literature.
Yan J; Luo M; Xiang L; Wu Y; Lin F
Clin Chim Acta; 2022 Mar; 528():1-5. PubMed ID: 35063457
[TBL] [Abstract][Full Text] [Related]
24. Laboratory and Genetic Investigation of Mutations Accounting for Congenital Fibrinogen Disorders.
Neerman-Arbez M; de Moerloose P; Casini A
Semin Thromb Hemost; 2016 Jun; 42(4):356-65. PubMed ID: 27019463
[TBL] [Abstract][Full Text] [Related]
25. Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation.
Asselta R; Robusto M; Platé M; Santoro C; Peyvandi F; Duga S
Thromb Res; 2015 Jul; 136(1):168-74. PubMed ID: 26006300
[TBL] [Abstract][Full Text] [Related]
26. Congenital hypofibrinogenemia: characterization of two missense mutations affecting fibrinogen assembly and secretion.
Platè M; Asselta R; Spena S; Spreafico M; Fagoonee S; Peyvandi F; Tenchini ML; Duga S
Blood Cells Mol Dis; 2008; 41(3):292-7. PubMed ID: 18676163
[TBL] [Abstract][Full Text] [Related]
27. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen.
Haverkate F; Samama M
Thromb Haemost; 1995 Jan; 73(1):151-61. PubMed ID: 7740487
[TBL] [Abstract][Full Text] [Related]
28. The molecular basis of quantitative fibrinogen disorders.
Asselta R; Duga S; Tenchini ML
J Thromb Haemost; 2006 Oct; 4(10):2115-29. PubMed ID: 16999847
[TBL] [Abstract][Full Text] [Related]
29. The amplitude of coagulation curves from thrombin time tests allows dysfibrinogenemia caused by the common mutation FGG-Arg301 to be distinguished from hypofibrinogenemia.
Jacquemin M; Vanlinthout I; Van Horenbeeck I; Debasse M; Toelen J; Schoeters J; Lavend'homme R; Freson K; Peerlinck K
Int J Lab Hematol; 2017 Jun; 39(3):301-307. PubMed ID: 28318107
[TBL] [Abstract][Full Text] [Related]
30. Differences in the function and secretion of congenital aberrant fibrinogenemia between heterozygous γD320G (Okayama II) and γΔN319-ΔD320 (Otsu I).
Mukai S; Ikeda M; Takezawa Y; Sugano M; Honda T; Okumura N
Thromb Res; 2015 Dec; 136(6):1318-24. PubMed ID: 26573395
[TBL] [Abstract][Full Text] [Related]
31. Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency.
Asselta R; Platè M; Robusto M; Borhany M; Guella I; Soldà G; Afrasiabi A; Menegatti M; Shamsi T; Peyvandi F; Duga S
Thromb Haemost; 2015 Mar; 113(3):567-76. PubMed ID: 25427968
[TBL] [Abstract][Full Text] [Related]
32. Structural and Functional Characterization of Four Novel Fibrinogen Mutations in
Ceznerová E; Kaufmanová J; Sovová Ž; Štikarová J; Loužil J; Kotlín R; Suttnar J
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054908
[TBL] [Abstract][Full Text] [Related]
33. Congenital hypofibrinogenemia associated with novel heterozygous fibrinogen Bbeta and gamma chain mutations.
Castaman G; Giacomelli SH; Duga S; Rodeghiero F
Haemophilia; 2008 May; 14(3):630-3. PubMed ID: 18393984
[No Abstract] [Full Text] [Related]
34. Clinical and molecular characterization of Iranian patients with congenital fibrinogen disorders.
Mohsenian S; Seidizadeh O; Mirakhorli M; Jazebi M; Azarkeivan A
Transfus Apher Sci; 2021 Dec; 60(6):103203. PubMed ID: 34275736
[TBL] [Abstract][Full Text] [Related]
35. Congenital Afibrinogenemia and Hypofibrinogenemia: Laboratory and Genetic Testing in Rare Bleeding Disorders with Life-Threatening Clinical Manifestations and Challenging Management.
Simurda T; Asselta R; Zolkova J; Brunclikova M; Dobrotova M; Kolkova Z; Loderer D; Skornova I; Hudecek J; Lasabova Z; Stasko J; Kubisz P
Diagnostics (Basel); 2021 Nov; 11(11):. PubMed ID: 34829490
[TBL] [Abstract][Full Text] [Related]
36. Cryoprecipitate: no longer the best therapeutic choice in congenital fibrinogen disorders?
Bevan DH
Thromb Res; 2009 Dec; 124 Suppl 2():S12-6. PubMed ID: 20109651
[TBL] [Abstract][Full Text] [Related]
37. A novel frameshift mutation in FGA (c.1846 del A) leading to congenital afibrinogenemia in a consanguineous Syrian family.
Levrat E; Aboukhamis I; de Moerloose P; Farho J; Chamaa S; Reber G; Fort A; Neerman-Arbez M
Blood Coagul Fibrinolysis; 2011 Mar; 22(2):148-50. PubMed ID: 21245743
[TBL] [Abstract][Full Text] [Related]
38. Three cases of abnormal fibrinogens: sumperk (Bbeta His67Leu), Unicov (Bbeta Gly414Ser), and Brno (gammaArg275His).
Kotlín R; Reicheltová Z; Sobotková A; Suttnar J; Salaj P; Pospísilová D; Smejkal P; Chrastinová L; Dyr JE
Thromb Haemost; 2008 Dec; 100(6):1199-200. PubMed ID: 19132250
[No Abstract] [Full Text] [Related]
39. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.
Yan J; Luo M; Cheng P; Liao L; Deng X; Deng D; Lin F
Int J Hematol; 2017 Apr; 105(4):506-514. PubMed ID: 27933517
[TBL] [Abstract][Full Text] [Related]
40. A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis.
Robert-Ebadi H; Le Querrec A; de Moerloose P; Gandon-Laloum S; Borel Derlon A; Neerman-Arbez M
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):697-9. PubMed ID: 18832913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
